TRIM15 inhibitors belong to a class of molecules that specifically target the TRIM15 protein, which is part of the tripartite motif (TRIM) family. TRIM proteins are characterized by a conserved tripartite structure consisting of a RING domain, one or two B-box domains, and a coiled-coil region. TRIM15, in particular, plays a critical role in cellular processes such as protein ubiquitination, where it functions as an E3 ubiquitin ligase. The ubiquitination process involves the attachment of ubiquitin molecules to target proteins, marking them for various cellular fates, including degradation via the proteasome, subcellular localization, or modulation of protein-protein interactions. Inhibitors of TRIM15 are designed to interfere with its enzymatic activity, thus modulating the post-translational modifications it governs. This modulation can affect multiple pathways, including those involved in protein stability, trafficking, and signal transduction.
The inhibition of TRIM15 can lead to downstream effects on various intracellular signaling cascades, as TRIM proteins are known to regulate the activity of specific substrates involved in processes like cell cycle regulation, immune signaling, and stress responses. By interfering with the ubiquitin ligase activity of TRIM15, these inhibitors could potentially alter the turnover rates and functional dynamics of key regulatory proteins. Structurally, TRIM15 inhibitors can vary, but they often contain moieties that specifically interact with the active sites or cofactor-binding regions of the TRIM15 protein, thereby preventing its normal function. These molecules are critical in the study of TRIM15's biological roles, as they provide researchers with tools to dissect the precise molecular mechanisms governed by TRIM15 in various cellular contexts. Through the use of such inhibitors, the mechanistic understanding of protein ubiquitination and its broader impact on cell signaling can be further explored.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Cycloheximide | 66-81-9 | sc-3508B sc-3508 sc-3508A | 100 mg 1 g 5 g | $41.00 $84.00 $275.00 | 127 | |
May halt protein synthesis, decreasing overall TRIM15 protein levels. | ||||||
Actinomycin D | 50-76-0 | sc-200906 sc-200906A sc-200906B sc-200906C sc-200906D | 5 mg 25 mg 100 mg 1 g 10 g | $74.00 $243.00 $731.00 $2572.00 $21848.00 | 53 | |
Could inhibit transcription, reducing TRIM15 mRNA synthesis. | ||||||
MG-132 [Z-Leu- Leu-Leu-CHO] | 133407-82-6 | sc-201270 sc-201270A sc-201270B | 5 mg 25 mg 100 mg | $60.00 $265.00 $1000.00 | 163 | |
An inhibitor of proteasomal degradation, possibly affecting TRIM15 protein turnover. | ||||||
Bortezomib | 179324-69-7 | sc-217785 sc-217785A | 2.5 mg 25 mg | $135.00 $1085.00 | 115 | |
May affect proteasomal activity, impacting TRIM15 protein degradation. | ||||||
Geldanamycin | 30562-34-6 | sc-200617B sc-200617C sc-200617 sc-200617A | 100 µg 500 µg 1 mg 5 mg | $39.00 $59.00 $104.00 $206.00 | 8 | |
Could influence protein folding by targeting Hsp90, affecting TRIM15 stability. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
May inhibit mTOR, influencing TRIM15 protein synthesis pathways. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Could impact PI3K pathways, indirectly affecting TRIM15 expression. | ||||||
(±)-JQ1 | 1268524-69-1 | sc-472932 sc-472932A | 5 mg 25 mg | $231.00 $863.00 | 1 | |
May modify transcriptional activity, potentially influencing TRIM15 expression. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
An inhibitor of JNK, possibly impacting signaling pathways relevant to TRIM15. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
Could affect p38 MAPK pathways, influencing signals related to TRIM15 expression. | ||||||